Determination of MIC & MBC

Similar documents
Evaluation of Antibacterial Effect of Odor Eliminating Compounds

CHAPTER 6 EVALUATION OF SELECTED PLANT EXTRACTS FOR EVALUATION OF SELECTED PLANT EXTRACTS FOR ANTI-ACNE ACTIVITY

Biological Consulting Services

Effect of various solvents on bacterial growth in context of determining MIC of various antimicrobials

Effect of various solvents on bacterial growth in context of determining MIC of various antimicrobials

SCREENING THE BIOACTIVE POTENTIAL OF PROTEIN ISOLATED FROM CYPRINUS CARPIO. Iyyanuchamy, S.K and A. Periyanayagasamy*

Antimicrobial activity of Terminalia chebula

Bacterial Survival In Synovial Fluid: Is S. aureus in the Knee Joint Persisting Despite Antibiotic Treatment?

CHAPTER 8 ANTIBACTERIAL ACTIVITY OF THE CRUDE ETHANOLIC EXTRACT AND THE ISOLATED COMPOUNDS FROM THE STEM OF COSTUS IGNEUS

Roula M. Abdel-Massih Dept. of Biology, University of Balamand, Lebanon

Preservative A15 Safe antimicrobial for cosmetics and pharmaceuticals

Preservative A2 Plus. 1. INCI Composition. 2. Overview. 3. Specification data. Diazolidinyl Urea 99.0% Iodopropynyl Butylcarbamate 1.

CHAPTER 2 MATERIALS AND MATHODS

SUPPORTING INFORMATION. Studies on antimicrobial evaluation of some 1-((1-(1H-benzo[d]imidazol-2-

*Corresponding author: ABSTRACT

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

Antibacterial activities of extracts and their fractions of leaves of Tridax procumbens Linn

ANTIBACTERIAL ACTIVITIES OF SELECTED MEDICINAL PLANTS AGAINST MRSA STRAINS ISOLATED FROM SURGICAL WOUND INFECTIONS

Against Aerobic Gram-Negative Bacilli

Screening of Chinese Medicinal Herbs for the Inhibition of Brucella melitensis

In vitro assessment of dual drug combinations to inhibit growth of Neisseria gonorrhoeae

Antioxidant and Antimicrobial Activities of the Extracts of Sophora flavescens

Adenium Biotech. Management: - Peter Nordkild, MD, CEO, ex Novo Nordisk, Ferring, Egalet - Søren Neve, PhD, project director, ex Lundbeck, Novozymes

Evaluation of Antibacterial and Antifungal Activities of Leaf and Seed Extracts of Croton Tiglium Plant against Skin Disease Causing Microbes

Antimicrobial Activity of Dentifrice Containing Xylitol on Mutans Streptococci

ANTIBACTERIAL TOOTHPASTE: DO NOT SWALLOW

Development of Guava Extract Chewable Tablets for Anticariogenic Activity against Streptococcus mutans

Calibration Protocols

Mr. Vipul R. Suryavanshi Department of Pharmaceutical Analysis Bombay College of Pharmacy, Kalina, Santacruz (E), Mumbai

QR Code for Mobile users

In-Vitro Antibacterial Activity of Crude Defatted Moringa Oleifera Seed Extract: Kill time study

Antibacterial Effect of Pulsatilla chinensis towards Staphylococcus aureus, Shigella dysenteriae, and Salmonella typhi

Chapter 4. Anti-bacterial studies of PUFA extracts from Sardinella longiceps and Sardinella fimbriata. 4.1 Introduction

BACTERIAL PLATING INSTRUCTIONS AND INTERPRETATION. SHELLFISH BACTERIAL WORKSHOP APRIL 26, 2017 SUSAN LARAMORE

SYNERGISTIC ACTIVITIES OF TWO PROPOLIS WITH AMPHOTERICIN B AGAINST SOME AZOLE-RESISTANT CANDIDA STRAINS. PART II

In vitro and Intracellular Activities of Peptide Deformylase. Inhibitor GSK against Legionella pneumophila Isolates

Preparation of Penicillins by Acylation of 6-Aminopenicillanic acid with Acyl Chlorides Week One: Synthesis

RICINOLEATE UPON BACTERIA

Effect of efflux pump inhibitors on antimicrobial resistance and in vivo colonization of Campylobacter jejuni

Commercial in Confidence

Media Fill Test Kits. Manufactured by. Making USP <797> compliance easy!

Study of Antibacterial Activity against Streptococcus Mutans of Lemon Seed Extract

Efficacy of Ceftaroline Fosamil against Escherichia coli and Klebsiella pneumoniae Strains in a rabbit meningitis model.

Laboratory Protocol. November 2017 Version 3. Henrik Hasman, Yvonne Agersø and Lina M Cavaco (DTU Food)

Effect of Spray Tank Materials on Anti-Bacterial Activities of Sodium Hypochlorite

Experimental Endocarditis Caused by Streptococcus sanguis:

Effect of P.betle in Dentifrice on Streptococcus mutans of Schoolchildren

An evaluation of 2.0 McFarland Etest method for detection of heterogeneous vancomycin-intermediate Staphylococcus aureus

The medicinal use of honey has been known since ancient

Impact of Sodium Reduction on Survival of Listeria monocytogenes in Sliced Process Cheese

THE SENSITIVITY OF STAPHYLOCOCCI AND OTHER WOUND BACTERIA TO ERYTHROMYCIN, OLEANDOMYCIN, AND SPIRAMYCIN

ESCMID Online Lecture Library. by author

The Evaluation of Essential Oils for Antimicrobial Activity

ANTI-MICROBIAL ACTIVITIES OF BETEL NUT (ARECA CATECHU LINN) SEED EXTRACTS

The Effect of Fragaria x ananassa Infusum on Salivary Mutans Streptococci

Jl. Perintis Kemerdekaan KM.5 Makassar 90231, South Sulawesi Indonesia.

Assessment of the potential for resistance to antimicrobial violet-blue light in Staphylococcus aureus

Received 30 March 2005; returned 16 June 2005; revised 8 September 2005; accepted 12 September 2005

Rifampin Resistance. Charlottesville, Virginia i0w organisms in Trypticase soy broth (BBL Microbiology

ANTIBACTERIAL ACTIVITY OF GYMNEMA SYLVESTRE HYDROALCOHOLIC LEAF EXTRACT.

Report on susceptibility of Salmonella serotypes in Belgium Vicky Jasson

COMPARATIVE ANTI MICROBIAL STUDY OF SHUDDHA KASISA AND KASISA BHASMA

Antimicrobial activity of some medicinal plants against multidrug resistant skin pathogens

Research Article. Antibacterial activity of Sivanar Vembu (Indigofera aspalathoides) against some human pathogenic bacteria

PROPOLIS AS A SOURCE OF NEW ANTI-PAENIBACILLUS LARVAE SUBSTANCES K. Bilikova 1, M. Popova 2, B, Trusheva 2, V. Bankova 2

Octa Journal of Biosciences

ANTIMICROBIAL ACTIVITY OF NON EDIBLE SEEDS AGAINST IMPORTANT PATHOGENIC MICROORGANISMS PROJECT REFERENCE NO.: 38S _B_MSC_010

METHOD COMPARISION FOR CLEANING CUTLERY HANDLED IN COMMERCIAL SETTINGS

Stability of Cefazolin Sodium Eye Drops

International Journal of Pharma and Bio Sciences A COMPARITIVE STUDY OF ANTIMICROBIAL ACTIVITY OF SOME HERBS AND THEIR SYNERGISTIC EFFECT ABSTRACT

Affinity of Doripenem and Comparators to Penicillin-Binding Proteins in Escherichia coli and ACCEPTED

Ueli von Ah, Dieter Wirz, and A. U. Daniels*

Action of Antifungal Imidazoles on Staphylococcus aureus

Evaluation of antioxidant and invitro cytotoxicity of crude fractions from the roots of Xanthiuim Strumarium

CHAPTER 4 IMMUNOLOGICAL TECHNIQUES

Loyola ecommons. Loyola University Chicago. Virginia Long Loyola University Chicago. Recommended Citation

Synergistic Effects of Vitamin B12 and Creatine on Microbes. Jake Rocchi CCHS, 11th grade 2nd year in PJAS

Synergism of Fosfomycin-Ampicillin and Fosfomycin-

NISIN. SYNONYMS INS No. 234 DEFINITION

22 Bicozamycin (Bicyclomycin)

By Tony Patsy, Pittsburgh Central Catholic, Grade 9 ARTIFICIAL SWEETENER EFFECTS ON MICROBIAL FLORA

Use of Conductance to Detect Bacteriocin Activity

International Journal of Food Nutrition and Safety, 2012, 1(2): International Journal of Food Nutrition and Safety

Bioprospecting of Neem for Antimicrobial Activity against Soil Microbes

Higher plants produced hundreds to thousands of diverse chemical compounds with different biological activities (Hamburger and Hostettmann, 1991).

EFFECTS OF OSMOTIC PRESSURE ON MICROBIAL GROWTH

A Study of antimicrobial activity of some spices

Antibacterial Activities of Ginkgo biloba L. Leaf Extracts

Received: 20 th Feb Revised: 24 th Feb-2012 Accepted: 28 th Feb-2012 Research article

Antimicrobial Effects of Vinegar. Daniel Crawford Grade 9 Central Catholic High School

Susceptibility testing of Pseudomonas aeruginosa and Staphylococcus aureus to some commonly used Hospital disinfectants

Recipes for Media and Solution Preparation SC-ura/Glucose Agar Dishes (20mL/dish, enough for 8 clones)

Kemaben ME. 1. INCI composition. 2. Overview. 3. Specification data. 4. Chemical-physical data. Phenoxyethanol Methylparaben Ethylparaben

Comparison of a Waterless, Scrubless CHG/Ethanol Surgical Scrub to Traditional CHG and Povidone-Iodine Surgical Scrubs

Transfection of Sf9 cells with recombinant Bacmid DNA

Antifungal activity of some plant extracts against Clinical Pathogens

Supplementary Figures

COMPARATIVE IN VITRO STUDY OF ANTIMICROBIALS AGAINST ORAL BIOFILMS OF STREPTOCOCCUS MUTANS

The Effects of Reiki on Bacteria Survivorship. Jordan Ciccone Central Catholic High School

EVALUATION OF ANTIMICROBIAL ACTIVITY OF SELECTIVE COX-2 INHIBITOR

Transcription:

1 Determination of MIC & MBC Minimum inhibitory concentrations (MICs) are defined as the lowest concentration of an antimicrobial that will inhibit the visible growth of a microorganism after overnight incubation, while minimum bactericidal concentrations (MBCs) known as the lowest concentration of antimicrobial that allow less than 0.1% of the inoculated bacteria to grow this mean that more than 99.9% of the bacteria should be killed. MIC and MBC can be determined by several techniques: 1. Tube dilution method ( macro or microtube) 2. Plate dilution method 3. Using spectrophotometer 4. Using epsilometer to determine MIC How to calculate MIC and MBC using tube dilution method? 1. Obtain antimicrobial powders directly from the manufacturer or from commercial sources. The agent must be supplied with a stated potency (mg or International Units per g powder, or as percentage potency). 2. Store powders in sealed containers in the dark at 4 C with a desiccant unless otherwise recommended by the manufacturer. 3. Prepare antibiotic stock solutions by using the following formula: Weight of powder (mg) = Volume of solvent (ml) X Concentration (µg/ml) Potency of powder (µg /mg). 4. Prepare serial dilution from the stock solution of the antimicrobial agent as it shown in the figure below. Each tube contain 1 ml of different concentrations of the antimicrobial agent 5. From broth inoculated with the bacteria to be tested and overnight incubated, transfer 1 ml of the bacterial broth to each tube containing antimicrobial agent. ( the broth used is Muller Hinton broth).

2 Note: the volume in the tubes duplicated, this mean that both the antimicrobial agent and bacterial concentration have been decreased to the half of the initial concentrations. 6. After an overnight incubation the tubes noticed to have decreased turbidity should be plated. The volume to be plated is important for calculation. 7. The antimicrobial agent concentration _in the first tube contain decreasing in turbidity ( inhibition of growth) or no growth_ considered as MIC. Note: For some drugs, MIC can be MBC as well, so we need to do calculations to find out the MBC. 8. After overnight incubation for the inoculated plates, the number of colonies in each plate should be counted. Thus the bacterial concentration of each tube can be determines using the following formula : Bacterial concentration= no. of colonies/ ( volume plated * dilution). By applying the concentration formula the bacterial concentration in the tube containing 8 µg of the drug contained 120 CFU/ml. Hereby, we need to know the percentage of grown cells from the initial bacterial concentration used.

3 9. The initial concentration of bacteria can be obtained or confirmed from plating the control tube containing 0 µg of drug. 10. The concentration of drug in the tube giving percentage of growth less than.1% considered as MBC.

4 Problems: 1. If the initial bacterial concentration was 6.2 10 8 CFU/µl, calculate MIC, MBC and number of colonies should be obtained in the control plate Initial bacterial concentration 6.2 10 8 CFU/µl. 0.5 ml of bacterial broth transferred to 1.5 ml broth containing tube.001 ml Volume plated in each tube.001 ml How many colonies?? 0 5 12

5 Solution: 1. MIC is the minimum concentration of drug that cause bacterial growth inhibition which is 8 µg/ml. 2. To find out MBC: we need to calculate the bacterial concentration of the last three tubes as well as the bacterial percentage from the initial concentration in each of them. The tube that established less than 0.1% bacterial growth should be considered MBC. Firstly: the initial bacterial concentration should be converted from CFU/µl to CFU/ml. This means the initial bacterial concentration is 6.2 10 5 CFU/ml a. In the tube of drug concentration 8 µg/ml C = 12/ ( 0.001 * 1) = 12000 CFU/ml Bacterial content percentage = (concentration at tube 8 µg/ml / initial Bacterial content percentage = (12000 / 3.1 10 5 ) * 100% = 3.8% b. In the tube of drug concentration 16 µg/ml C = 5/ ( 0.001 * 1) = 5000 CFU/ml Bacterial content percentage = (concentration at tube 16 µg/ml / initial Bacterial content percentage = (5000 / 3.1 10 5 ) * 100% = 1.6% So the drug concentration 32 µg/ml should be considered MBC. Note: If the dilution considered is ½ in the concentration formula, the initial bacterial concentration should be considered 6.2 10 5 CFU/ml in the percentage formula. 3. To find out the no. of colonies should be obtained in the control plate Total dilution in the control tube = 0.5 / (0.5 + 1.5) = 0.25 3.1 10 5 =?? / ( 0.001 * 0.25) So, no. of colonies = 77.5 ~ 78 CFU

6 2. Using 2.5 10 5 CFU/ml was initial concentration of bacteria calculate MIC, MBC, and volume plated in the control plate. 0.5 ml of the bacterial broth transferred to 1.5 ml broth tube Volume plated??? Volume plated in each tube 0.1 ml 31 colonies 5 12

7 Solution: 1. MIC is the minimum concentration of drug that cause bacterial growth inhibition which is 8 µg/ml. 2. To find out MBC: we need to calculate the bacterial concentration of the last three tubes as well as the bacterial percentage from the initial concentration in each of them. The tube that establish less than 0.1% bacterial growth should be considered MBC. a. In the tube of drug concentration 8 µg/ml C = 12/ ( 0.1 * 1) = 120 CFU/ml Bacterial content percentage = (concentration at tube 8 µg/ml / initial Bacterial content percentage = (120/1.25 10 5 ) * 100% = 0.096% So the drug concentration 8 µg/ml can be considered as both MIC & MBC. Note: If the dilution considered is ½ in the concentration formula, the initial bacterial concentration should be considered 2.5 10 5 CFU/ml in the percentage formula. 3. To find out the volume plated should be obtained in the control plate Total dilution in the control tube = 0.5 / (0.5 + 1.5) = 0.25 1.25 10 5 = 31 / (?? * 0.25) So, volume plated = 9.9 10-4 ml

8 3. Using 1 10 6 CFU/ml as initial bacterial concentration, Find MIC and MBC Day 1 Day 2 Day 3

9 Solution: 1. MIC is the minimum concentration of drug that cause bacterial growth inhibition which is 16 µg/ml. 2. To find out MBC: we need to calculate the bacterial concentration of the last three tubes as well as the bacterial percentage from the initial concentration in each of them. The tube that establish less than 0.1% bacterial growth should be considered MBC. a. In the tube of drug concentration 16 µg/ml C = 7/ ( 0.01 * 1) = 700 CFU/ml Bacterial content percentage = (concentration at tube 16 µg/ml / initial Bacterial content percentage = (700/ 0.5 10 6 ) * 100% = 0.14% So the drug concentration 32 µg/ml can be considered as both MIC & MBC. Note: If the dilution considered is ½ in the concentration formula, the initial bacterial concentration should be considered 1 10 6 CFU/ml in the percentage formula.

10 4.Using data in the figure calculate the initial bacterial concentration, MIC and MBC

11 Solution: 1. To find out the initial bacterial concentration Total dilution in the control tube = 0.5 / (0.5 + 1) = 1/3?? CFU/ml = 80 / ( 0.001 * 1/3) Bacterial concentration = 2.4 10 5 CFU/ml So, the initial bacterial concentration = 4.8 10 5 CFU/ml 2. MIC is the minimum concentration of drug that cause bacterial growth inhibition which is 8 µg/ml. 3. To find out MBC: we need to calculate the bacterial concentration of the last three tubes as well as the bacterial percentage from the initial concentration in each of them. The tube that establish less than 0.1% bacterial growth should be considered MBC. b. In the tube of drug concentration 8 µg/ml C = 30/ ( 0.1 * 1) = 300 CFU/ml Bacterial content percentage = (concentration at tube 8 µg/ml / initial Bacterial content percentage = (300 / 2.4 10 5 ) * 100% = 0.125% c. In the tube of drug concentration 16 µg/ml C = 5/ ( 0.1 * 1) = 50 CFU/ml Bacterial content percentage = (concentration at tube 16 µg/ml / initial Bacterial content percentage = (50 / 2.4 10 5 ) * 100% = 0.020% So the drug concentration 16 µg/ml should be considered as MBC. Note: If the dilution considered is ½ in the concentration formula the initial bacterial concentration should be considered 4.8 10 5 CFU/ml in the percentage formula.